OSL got a good mention on Your Money Your Call last night with Marcus Hughes from LHC Capital. He believed OSL was undervalued and potentially the next Sirtex but in the pancreatic cancer space. IMO interest has turned in this stock and volume has picked up in the last few weeks as the market becomes aware of the potential unfolding here. I believe we are heading to all time highs in coming months. SRX's run over 5 years may well be mimicked at a smaller scale by OSL as developments advance in their plantable nuclear medicine (radiotherapy) device.
OSL got a good mention on Your Money Your Call last night with...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.070(5.69%) |
Mkt cap ! $16.49M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.25 | $1.11 | $72.36K | 60.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9286 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 412 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |